Page 461 - Environmental Nanotechnology Applications and Impacts of Nanomaterials
P. 461
438 Potential Impacts of Nanomaterials
Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., and Langer, R. (1994)
“Biodegradable long-circulating polymeric nanospheres,” Science, 18(263):1600–1603.
Gurr, J.-R., Wang, A., Chen, C.-H., and Jan, K.-Y. (2005) “Ultrafine titanium dioxide par-
ticles in the absence of photoactivation can induce oxidative damage to human bronchial
epithelial cells,” Toxicology, 213:66–73.
Gutteridge, J.M., Rowley, D.A., and Halliwell, B. (1982) “Superoxide-dependent formation
of hydroxyl radical and lipid peroxidation in the presence of iron salt: detection of cat-
alytic iron and antioxidant activity in extracellular fluids,” Biochemistry. J., 206:605–609.
Hardman, R. (2006) “A toxicologic review of quantum dots: toxicity depends on physico-
chemical and environmental factors,” Environmental Health Perspectives, 114(2):165–172.
Hart, G.A., and Hesterberg, T.W. (1998) “In vitro toxicity of respirable-size particles of
diatomaceous earth and crystalline silica compared with asbestos and titanium dioxide,”
J. Occupational. Environmental. Medicine., 40(1):29–42.
Heller, D.A., Baik, S., Eurell, T.A., and Strano, M.S. (2005) “Single-walled carbon nanotube
spectroscopy in live cells: towards long-term labels and optical sensors,” Adv. Materials,
17:2793–2799.
Hoffman, H.T., Quets, J., Toshiaki, T., Funk, G.F., McCulloch, T.M., Graham, S.M.,
Robinson, R.A., Schuster, M.E., and Yuh, W.T. (2000) “Functional magnetic resonance
imaging using iron oxide particles in characterizing head and neck adenopathy,”
Laryngoscope, 110:1425–1430.
Huczko, A., Lange, H., Calko, E., Grubek-Jaworska, H., and Droszcz, P. (2001). “Physiological
testing of carbon nanotubes: are they asbestos-like?” Fullerene Sci. Technol., 9:251–254.
Ito, A., Shinkai, M., Honda, H., and Kobayashi, T. (2001) “Heat-inducible TNF alpha gene
therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-
targeted therapy,” Cancer Gene Ther., 8(9):649–654.
Ito, A., Shinkai, M., Honda, H., and Kobayashi, T. (2005) “Medical application of func-
tionalized magnetic nanoparticles,” J. Biosci. Bioeng., 100:1–11.
Jaiswal, J.K., Mattoussi, H., Mauro, J.M., and Simon, S.M. (2003) “Long-term multiple
color imaging of live cells using quantum dot bioconjugates,” Nature Biotech., 21:47–51.
Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhoa, Y., and Guo, X. (2005)
“Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and
fullerene,” Environ. Sci. Technol., 39:1378–1383.
Jordan, A., Wust, P., Scholz, R, Tesche, B., Fahling, H., Mitrovics, T., Vogl, T., Cervos-
Navarro, J., and Felix, R. (1996) “Cellular uptake of magnetic fluid particles and their
effects on human carcinoma cells exposed to AC magnetic fields in vitro,” Int. J.
Hyperthermia, 12(6):705–722.
Josephson, L., Tung, C.H., Moore, A., and Weissleder, R. (1999) “High-efficiency intra-
cellular magnetic labelling with novel superparamagnetic-tat peptide conjugates,”
Bioconjug. Chem., 10:186–191.
Jovin, T.M. (2003) “Quantum dots finally come of age,” Nat. Biotechnol., 21:32–33.
Jung, C.W., and Jacobs, P. (1995) “Physical and chemical properties of superparamagnetic
iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil,” Magn. Res.
Imaging, 13:661–674.
Kagan, V.E., Tyruina, Y.Y., Tyurin, V.A., Konduru, N.V., Potapovich, A.I., Osipov, A.N.,
Kisin, E.R., Schwegler-Berry, D., Mercer, R., Castranova, V., Shvedova, A.A. (2006).
“Direct and indirect effects of single walled carbon nanotubes on RAW 264.7
macrophages: role of iron,” Toxicology Letters, 165(1):88–100.
Kam, N.W.S., Jessop, T.C., Wender, P.A., and Dai, H. (2004) “Nanotube molecular trans-
porters: internalization of carbon nanotube-protein conjugates into mammalian cells,”
J. Am. Chem. Soc., 126:6850–6851.
Kim, J.S., Yoon, T.-J., Yu, K.N., Kim, B.G., Park, S.J., Kim, H.W., Lee, K.H., Park, S.B., Lee,
J.-K., and Cho, M.H. (2006) “Toxicity and tissue distribution of magnetic nanoparticles
in mice,” Toxicol. Sci., 89(1):338–347.
Kirschvink, J.L., Kobayashi-Kirschvink, A., and Woodford, B.J. (1992) “Magnetite bio-
mineralization in the human brain,” Proc. Natl. Acad. Sci. USA, 89:7683–7687.
Kreuter, J. (1994) “Drug targeting with nanoparticles,” Eur. J. Drug Metab. Pharmacok.,
19(3):253–256.
Kroto, H.W., Hearth, J.R., O’Brien, S.C., Curl, R.F., and Smalley, R.E. (1985) “C 60 :
Buckminsterfullerene,” Nature, 318:162–163.

